Toledo-Pastrana T, García-Hernández MJ, Carrizosa-Esquivel AM, Camacho-Martínez FM. Evaluation of 25 years of phototherapy for treating psoriasis at a teaching hospital in southern Spain.
An Bras Dermatol 2016;
90:473-8. [PMID:
26375215 PMCID:
PMC4560535 DOI:
10.1590/abd1806-4841.20153694]
[Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
Abstract
BACKGROUND
For years, phototherapy has been used in a wide range of skin diseases, which is
unsurprising as skin is the anatomical feature most directly exposed to light,
especially in psoriasis. Although the role of light therapy has been replaced by
different therapeutic modalities in recent years, this treatment is now an
established option for many skin diseases.
OBJECTIVES
The aim was to characterize the patient population thathad received the
aforementioned treatment in the Virgen Macarena Health Area in Seville (Spain)
between June 1985 and October 2011.
METHODS
We have designed a descriptive study with a univariate analysis covering 443
treatments with light therapy, all administered to the same number of patients
suffering from psoriasis.
RESULTS
79.15% of patients were discharged due to improvement or healing, while the 20.85%
were discharged due to other reasons. The average total accumulative dose was
131.53 J/cm2. We do not detected an increase in proportion in patients for develop
NMSK after light therapy treatment.
CONCLUSIONS
We consider that phototherapy is still an effective and efficient treatment that
will have to be reconsidered in the current macroeconomic context.
Collapse